The South Korean biotech firm plans to list via a SPAC merger with SilverBox Corp IV, illustrating how special-purpose acquisition companies provide expedited paths to public markets for crypto-related businesses. This route avoids traditional IPO hurdles while offering capital for Bitcoin treasury development.
SPAC mergers are particularly attractive for firms with unconventional business models—like those holding Bitcoin as a primary treasury asset—as they allow clearer valuation narratives than standard IPOs. The structure provides immediate liquidity and access to retail investors.
This trend reflects maturation in crypto finance, with KindlyMD also pursuing a merger (with Nakamoto Holdings) after raising $763 million. Such moves signal that institutional-grade cryptocurrency operations are achieving sufficient scale for public markets.
